Daiichi Sankyo Announces First European Approval For Sevikar HCT(R), A New Three-in-one Combination Product For The Treatment Of High Blood Pressure*
MUNICH, December 20, 2010 /PRNewswire/ -- Daiichi Sankyo Europe announced today that Sevikar HCT(R) is now approved in Germany, the first market to launch this new once-daily three-in-one combination…